Balaxi Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
73.27
63.77
58.05
60.65
55.00
Other Income Qtr Cr-4.11-1.85-1.79-0.130.28
Operating Revenues Qtr77.3865.6259.8360.7854.72

*All values are in Cr.

Operating Expenses Qtr
66.79
55.54
46.37
47.13
43.96
Operating Profit Qtr
10.59
10.09
13.47
13.66
10.76
EBIDT Qtr Cr
6.48
8.24
12.77
15.17
16.69
Depreciation Qtr
0.46
0.49
0.67
0.48
0.66
Net Profit Qtr
4.59
6.48
10.93
13.59
14.43
Basic EPS Qtr
0.84
1.17
10.41
13.29
14.10
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -